Myriad Genetics (MYGN) EBT Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) EBT Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 406.19 Mn | 281.79 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.22% |
| Dec 31, 2025 | 37.60% |
| Sep 30, 2025 | 9.73% |
| Jun 30, 2025 | -41.39% |
| Mar 31, 2025 | 25.84% |
| Dec 31, 2024 | -27.95% |
| Sep 30, 2024 | 1.01% |
| Jun 30, 2024 | -37.03% |
| Mar 31, 2024 | -58.01% |
| Dec 31, 2023 | -61.46% |
| Sep 30, 2023 | -139.32% |
| Jun 30, 2023 | -53.24% |
| Mar 31, 2023 | -42.88% |
| Dec 31, 2022 | -62.42% |
| Sep 30, 2022 | -20.41% |
| Jun 30, 2022 | -24.57% |
| Mar 31, 2022 | -45.64% |
| Dec 31, 2021 | -40.81% |
| Sep 30, 2021 | 52.03% |
| Jun 30, 2021 | 50.84% |